About this event
- Date and time Fri 3 Nov 2023 from 9:00am to 6:00pm
- Location Royal Society of Medicine
- Organised by Digital Health
Digital Twins are established in other industries but are only now being incorporated into healthcare. They refer to virtual representations or simulations of real-world medical entities, processes, or systems. These digital replicas are created by collecting and integrating various data sources, such as medical records, patient data, and sensor data to model and simulate healthcare-related elements using advanced technology like artificial intelligence (AI) and machine learning (ML).
Join this exciting and unique event that will provide an introduction to digital twins and their potential for improving both personalised medicine and healthcare provision. It will explore how interventions are being tailored to the individual, how clinical trials could be transformed, what building a virtual human involves the implications for prevention and sustainability in healthcare and the regulatory and ethical questions posed by such technology. This is a unique opportunity for the RSM to host an event with thought leadership and pioneers, and lead the way in sharing options and considering how to manage potential risks of digital twins healthcare.
By attending this event, you will:
- Understand what digital twins could mean for clinical practice and pathways
- Review the regulatory pathways e.g. FDA, MHRA, MDU and explore the ethical considerations
- Examine where digital twins are in the research and provider landscape
- Learn from those involved in insilico trials
- Explore how digital twins could impact sustainability and healthcare accessibility for all sections of the population
- Hear a critique of the role of AI: explainability and limits, keeping it safe
- Discuss the way ahead
Follow us on:
Facebook
Instagram
LinkedIn
Twitter
YouTube
We would like to thank our sponsors BiteWorld, IBM and The Technology Partnership for their support of this meeting.
Agenda
View the programme
Registration, tea and coffee
Welcome and introduction
Dr Julia Manning, President, Digital Health Council, Royal Society of Medicine
Virtual you: The medical revolution
Dr Roger Highfield, Science Director, Science Museum Group
Session 1: Tailoring interventions to the individual
Lessons from other industries
Dr Mark Davies, Chief Health Officer, IBM
Digital twins for pregnancy
Professor Michelle Oyen, Inaugural Director of the new Center for Women’s Health Engineering, Washington University, St Louis, USA
The role of synthetic data
Mr Matthew Whitty, Director of Commercial Partnerships, MDClone
Questions and answers
Tea and coffee break
Session 2: Accelerating clinical trials
Creating a digital biological twin for cancer patients
Professor Tony Ng, Head of School, School of Cancer and Pharmaceutical Sciences, King's College London and Vice President, Digital Biological Twin Unit, GSK
Digital twins in clinical trials
Dr Wahbi El-Bouri, Fellow, University of Liverpool
Cardiac digital twins for in silico trials
Dr Caroline Roney, Lecturer, Computational Medicine, Queen Mary University of London
Questions and answers
Building a virtual human
Professor Andrea Townsend-Nicholson, Professor, Biochemistry and Molecular Biology, University College London
Lunch
Session 3: Patients, workflows and sustainability
Weclome back
Dr Azeem Alam, Council member, Digital Health Council, Royal Society of Medicine
Improving processes through comparisons and virtual trials
Mr Jacob Koris, GIRFT Innovation and Technology Lead, NHS England and NHS Improvement
Supercomputers and virtual humans: The next medical revolution
Dr Mariano Vazquez, Co-Founder and Chief Technology Officer, ELEM Biotech
Hacking patient enrolment using digital twins
Dr Ed Roberts, Chief Product Officer, Iceberg
Questions and answers
Session 4: Patients, safety, regulation and ethics
Digital twins and complexity
Dr Saira Ghafur, Lead for Digital Health, Institute of Global Health Innovation, Imperial College London
Can real-world patients really benefit?
Dr Sheuli Porkess, Chief Medical Officer and Business Unit Director, Precisia Life Sciences, a C2-AI business
How to build a human digital twin – Regulatory considerations
Mr Benedikt von Thüngen, Founder and Chief Executive Officer, Sanome
Questions and answers
Tea and coffee break
Welcome back
Dr Grace Hatton, Council Member, Digital Health Council, Royal Society of Medicine
Brick by brick: Reflections from the day using LEGO® SERIOUS PLAY® methodology
Dr Matt Dexter, User Experience Consultant, TTP
Digital twins - State of the art
Professor Peter Coveney, Associate Director, Advanced Research Computing Centre, University College London and Director, Centre for Computational Science, University College London
Closing remarks
Dr Julia Manning
Close of meeting
Followed by drinks reception
Sponsors
Location
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
Registration for this event will close at 1:00am on Thursday 2 November 2023. Late registrations will not be accepted.
The agenda is subject to change at any time
If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenter’s and RSM’s discretion.
All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.
This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.